Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Chiu

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Annals of the New York Academy of Sciences|February 1, 2023
Respiratory viruses: New frontiers-a Keystone Symposia reportJennifer Cable, Jie Sun, In Su Cheon, et al.
The Lancet. Microbe|May 4, 2024
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection studySusan Jackson, Julia L Marshall, Andrew Mawer, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Lack of association between HLA and asymptomatic SARS-CoV-2 infectionAstrid Marchal, Elizabeth T Cirulli, Iva Neveux, et al.
HGG Advances|April 28, 2024
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infectionAstrid Marchal, Elizabeth T Cirulli, Iva Neveux, et al.
Plos One|July 1, 2025
Understanding the interaction of upper respiratory tract infection with respiratory syncytial virus and Streptococcus pneumoniae using a human challenge model: a multicenter, randomized controlled study protocolSanjita Brito-Mutunayagam, David O Hamilton, Elena Mitsi, et al.
Nature Medicine|April 1, 2022
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adultsBen Killingley, Alex J Mann, Mariya Kalinova, et al.
Haematologica|September 22, 2018
Daratumumab plus lenalidomide and dexamethasone <i>versus</i> lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUXMeletios A Dimopoulos, Jesus San-Miguel, Andrew Belch, et al.
Nature Medicine|July 1, 2026
Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infectionLoukas Papargyris, Jiayun Xu, Claire Broderick, et al.
Annals of the New York Academy of Sciences|January 14, 2022
Innovative vaccine approaches-a Keystone Symposia reportJennifer Cable, Rino Rappuoli, Elizabeth J Klemm, et al.
Nature Communications|November 30, 2024
SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infectionsJoshua Rosenheim, Rishi K Gupta, Clare Thakker, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Annals of the New York Academy of Sciences|February 1, 2023
Respiratory viruses: New frontiers-a Keystone Symposia reportJennifer Cable, Jie Sun, In Su Cheon, et al.
The Lancet. Microbe|May 4, 2024
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection studySusan Jackson, Julia L Marshall, Andrew Mawer, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Lack of association between HLA and asymptomatic SARS-CoV-2 infectionAstrid Marchal, Elizabeth T Cirulli, Iva Neveux, et al.
HGG Advances|April 28, 2024
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infectionAstrid Marchal, Elizabeth T Cirulli, Iva Neveux, et al.
Plos One|July 1, 2025
Understanding the interaction of upper respiratory tract infection with respiratory syncytial virus and Streptococcus pneumoniae using a human challenge model: a multicenter, randomized controlled study protocolSanjita Brito-Mutunayagam, David O Hamilton, Elena Mitsi, et al.
Nature Medicine|April 1, 2022
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adultsBen Killingley, Alex J Mann, Mariya Kalinova, et al.
Haematologica|September 22, 2018
Daratumumab plus lenalidomide and dexamethasone <i>versus</i> lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUXMeletios A Dimopoulos, Jesus San-Miguel, Andrew Belch, et al.
Nature Medicine|July 1, 2026
Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infectionLoukas Papargyris, Jiayun Xu, Claire Broderick, et al.
Annals of the New York Academy of Sciences|January 14, 2022
Innovative vaccine approaches-a Keystone Symposia reportJennifer Cable, Rino Rappuoli, Elizabeth J Klemm, et al.
Nature Communications|November 30, 2024
SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infectionsJoshua Rosenheim, Rishi K Gupta, Clare Thakker, et al.
Pageof 13